UnitedHealth Group Incorporated (UNH)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for UNH is $460.17, 14.6% above the last close of $401.43 on Oct 16, 2026; targets range from $313.26 to $529.12. Rating consensus: Buy.
Snapshot
- P/E22.9x
- P/E vs sector-18.6%
- P/E vs own-1.6%
- Target upside+14.6%
- ConsensusBuy
- Market cap$360B
- FCF yield+6.3%
- Insiders-$661K
- Earnings in96d
- News
Why it moved
UnitedHealth Group Incorporated (UNH) fell 1.3% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
6 stories on the day (30-day average 3.7).
- UnitedHealth: Q3 Confirms The Bull Case
- UnitedHealth Group Incorporated $UNH Holdings Boosted by Annex Advisory Services LLC
- Assenagon Asset Management S.A. Sells 452,536 Shares of UnitedHealth Group Incorporated $UNH
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $401.43 · +15.5% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50↑ in ~8d
- RSI63
- Support-0.9%
- Resistance+2.7%
- Off 52w high-7.4%
- Off ATH-32.7%
- 52w range$401.43
- Bollingerabove upper
- MACD4.22
- ATR+3.0%
- Volume1.4x
Analyst price targets
24 firms with a target in the last 12 months · last close $401.43 · as of Oct 16, 2026
Strong buy 7 · Buy 15 · Hold 4 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q3 FY2026: Revenue -0.4% year over year, free cash flow 3.8% of revenue, operating margin 5.8%.
| Q3 FY2026 | Sep 30, 2026 | $113B | 4.56 | $4.26B | 100.0% | 5.8% | 3.6% |
| Q2 FY2026 | Jun 30, 2026 | $112B | 6.05 | $10.25B | 32.7% | 7.1% | 4.9% |
| Q1 FY2026 | Mar 31, 2026 | $112B | 6.90 | $8.15B | 22.7% | 8.0% | 5.6% |
| Q4 FY2025 | Dec 31, 2025 | $113B | 0.01 | $160M | 16.3% | 0.3% | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | $113B | 2.59 | $5.05B | 18.2% | 3.8% | 2.1% |
| Q2 FY2025 | Jun 30, 2025 | $112B | 3.74 | $6.3B | 17.9% | 4.6% | 3.1% |
| Q1 FY2025 | Mar 31, 2025 | $110B | 6.85 | $4.56B | 21.7% | 8.3% | 5.7% |
| Q4 FY2024 | Dec 31, 2024 | $101B | 5.98 | $1.46B | 21.1% | 7.7% | 5.5% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | $285.42 | +0.7% | 0.0% | -1.4% | 80.4 | $504B | ||
| 2 | $401.43 | -1.3% | -7.4% | +14.6% | 22.9 | $360B | ||
| 3 | $145.95 | +0.5% | -6.2% | +7.7% | 116.8 | $360B | ||
| 4 | $92.36 | -0.2% | -16.0% | +20.9% | 24.4 | $118B | ||
| 5 | $428.26 | 0.0% | 0.0% | +1.9% | 19.0 | $92.88B | ||
| 6 | $302.30 | +1.2% | -0.2% | +10.9% | 12.5 | $79.88B | ||
| 7 | $413.16 | -4.4% | -4.7% | +15.7% | 39.1 | $49.63B | ||
| 8 | $69.16 | -1.9% | -1.9% | -0.5% | — | $34.16B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.